Download PDF
CC BY-NC-ND 4.0 · Arch Plast Surg 2022; 49(04): 479-481
DOI: 10.1055/s-0042-1751102
Cosmetic
Topic

Five Factors to Consider before Treatment of a Hyaluronic Acid Filler-Induced Vascular Complications

Won Lee 
1   Scientific Faculty of the Minimal Invasive Plastic Surgery Association, Yonsei E1 Plastic Surgery Clinic, Anyang, South Korea
› Author Affiliations
› Further Information
   Permissions and Reprints

Soft tissue fillers are common aesthetic procedures for facial rejuvenation.[1] Among the fillers in the market, hyaluronic acid filler has been the most popular because it is degraded by hyaluronidase. The most serious complications of filler injections are vascular complications, such as skin necrosis and ocular sequelae. Various treatment modalities, including hyaluronidase injection, have been proposed. Hyaluronidase, which normally exists in human tissues, dissolves hyaluronic acid. It degrades the β 1,4 chain of the disaccharide hyaluronic acid. The hyaluronic acid filler can be degraded by hyaluronidase when vascular complications develop. However, multiple factors must be considered before injecting hyaluronidase. This report proposed five important considerations for hyaluronidase injection.



Publication History

Article published online:
30 July 2022

© 2022. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 The aesthetic society's cosmetic surgery national data bank: statistics 2019. Aesthet Surg J 2020; 40 (01, Suppl 1): 1-26
    Search in Google Scholar
  • 2 DeLorenzi C. New high dose pulsed hyaluronidase protocol for hyaluronic acid filler vascular adverse events. Aesthet Surg J 2017; 37 (07) 814-825
    CrossrefPubMedSearch in Google Scholar
  • 3 Bailey SH, Fagien S, Rohrich RJ. Changing role of hyaluronidase in plastic surgery. Plast Reconstr Surg 2014; 133 (02) 127e-132e
    CrossrefPubMedSearch in Google Scholar
  • 4 Lee W, Oh W, Oh SM, Yang EJ. Comparative effectiveness of different interventions of perivascular hyaluronidase. Plast Reconstr Surg 2020; 145 (04) 957-964
    CrossrefPubMedSearch in Google Scholar